Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment

NCT04179162 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Non-Muscle Invasive Bladder Cancer (NMIBC)

Interventions

DRUG: Bacillus Calmette-Guérin (BCG)
DRUG: Gemcitabine

Sponsor

Memorial Sloan Kettering Cancer Center